Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE-TRANSACT
NCT07365150Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by The University of Hong Kong. Primary endpoints: Trial recruitment rate and Trial retention rate at 6 months. Started Jan 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07365150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07365150.